“…We demonstrated that the 67-kDa monomeric laminin receptor (67LR), which is overexpressed (Martignone et al, 1993;Ménard et al, 1998) and released by various tumor cell types (Karpatová et al, 1996;Starkey et al, 1999), changes the conformation of the laminin adhesion molecule upon binding to it . Because the integrin recognition domains of laminin appear to be conformation-dependent (Mercurio, 1995), 67LR-modified laminin interacts more readily with integrins and with other molecules that normally do not participate significantly in laminin binding to the cell surface (Ramos et al, 1990;Feldman et al, 1991;Kleinman et al, 1991;Magnifico et al, 1996). This mechanism provides the cells with a greater number of binding sites and modulates the interaction between tumor cells and laminin, with consequences for metastatic potential (Pellegrini et al, 1995).…”